Skalski Linda M, Watt Melissa H, MacFarlane Jessica C, Proeschold-Bell Rae Jean, Stout Jason E, Sikkema Kathleen J
doctoral student, Department of Psychology and Neuroscience, Duke University, Durham, North Carolina.
assistant research professor, Duke Global Health Institute, Duke University, Durham, North Carolina.
N C Med J. 2015 Jul-Aug;76(3):148-55. doi: 10.18043/ncm.76.3.148.
The HIV/AIDS epidemic is a significant public health concern in North Carolina, and previous research has pointed to elevated mental health distress and substance use among HIV-infected populations, which may impact patients' adherence to medications. The aims of this study were to describe the prevalence of mental health and substance use issues among patients of a North Carolina HIV clinic, to examine differences by demographic characteristics, and to examine factors associated with suboptimal adherence to HIV medications.
This study was a secondary analysis of clinical data routinely collected through a health behavior questionnaire at a large HIV clinic in North Carolina. We analyzed data collected from February 2011 to August 2012.
The sample included 1,398 patients. Overall, 12.2% of patients endorsed current symptomology indicative of moderate or severe levels of depression, and 38.6% reported receiving a psychiatric diagnosis at some point in their life. Additionally, 19.1% had indications of current problematic drinking, and 8.2% reported problematic drug use. Nearly one-quarter (22.1%) reported suboptimal adherence to HIV medications. Factors associated with poor adherence included racial/ethnic minority, age less than 35 years, and indications of moderate or severe depression.
The questionnaire was not completed systematically in the clinic, which may limit generalizability, and self-reported measures may have introduced social desirability bias.
Patients were willing to disclose mental health distress, substance use, and suboptimal medication adherence to providers, which highlights the importance of routinely assessing these behaviors during clinic visits. Our findings suggest that treating depression may be an effective strategy to improve adherence to HIV medications.
艾滋病毒/艾滋病疫情是北卡罗来纳州一个重大的公共卫生问题,先前的研究指出,艾滋病毒感染人群的心理健康困扰和药物使用情况有所增加,这可能会影响患者对药物的依从性。本研究的目的是描述北卡罗来纳州一家艾滋病毒诊所患者中心理健康和药物使用问题的患病率,按人口统计学特征检查差异,并检查与艾滋病毒药物依从性欠佳相关的因素。
本研究是对通过北卡罗来纳州一家大型艾滋病毒诊所的健康行为问卷常规收集的临床数据进行的二次分析。我们分析了2011年2月至2012年8月收集的数据。
样本包括1398名患者。总体而言,12.2%的患者认可当前表明中度或重度抑郁水平的症状,38.6%的患者报告在其生命中的某个时刻接受过精神科诊断。此外,19.1%的患者有当前存在问题饮酒的迹象,8.2%的患者报告有问题药物使用情况。近四分之一(22.1%)的患者报告对艾滋病毒药物的依从性欠佳。与依从性差相关因素包括种族/族裔少数群体、年龄小于35岁以及中度或重度抑郁的迹象。
该问卷在诊所并非系统完成,这可能会限制其普遍性,且自我报告的测量方法可能引入了社会期望偏差。
患者愿意向医护人员披露心理健康困扰、药物使用情况和药物依从性欠佳的情况,这凸显了在门诊就诊期间常规评估这些行为的重要性。我们的研究结果表明,治疗抑郁症可能是提高艾滋病毒药物依从性的有效策略。